Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The effect of Syntex adjuvant formulation (SAF-m) on humoral immunity to the influenza virus in the mouse.

Vaccine - 1 Apr 1997

Hjorth R N, Bonde G M, Piner E D, Goldberg K M, Levner M H

Abstract excerpt

Syntex adjuvant in its microfluidized form (SAF-m) was equal to or superior to Freund's complete adjuvant in stimulating an enhanced hemagglutination inhibition (HI) antibody response in mice to trivalent influenza virus vaccine (TIV). There was an average 16-fold increase in HI titer for the three components of the vaccine with no significant differences among strains. The increased serum antibodies correlated...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adjuvants, Immunologic
Share to Antibodies, Viral
Share to Cryopreservation

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genetic Variation

Share to Influenza, Human

Share to Influenza Vaccines

Source

Identifiers

PMID: 9160522
DOI: 10.1016/s0264-410x(97)00216-8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

The effect of Syntex adjuvant formulation (SAF-m) on humoral immunity to the influenza virus in the mouse.PMID 9160522Read ↗

LiteVax-adjuvanted influenza vaccine induces transient interferon-driven innate activation and accelerates early IgG3 responses in older adultsSemantic proximity Read ↗

A multicomponent intranasal adjuvant drives durable humoral, cellular, and mucosal immune responses to SARS-CoV-2 in young and aged mice.Semantic proximity Read ↗

LiteVax-adjuvanted influenza vaccine induces transient interferon-driven innate activation and accelerates early IgG3 responses in older adultsSemantic proximity Read ↗

Accelerated vaccine induction of IgM neutralising antibody enables vaccine protection against same day lethal influenza virus challengeSemantic proximity Read ↗

Adjuvant-dependent effects on the safety and efficacy of inactivated SARS-CoV-2 vaccines during heterologous infection by a SARS-related coronavirusSemantic proximity Read ↗

Kinetically activating nanovaccine mimicking multidimensional immunomodulation of natural infection for broad protection against heterologous viruses in animal modelsSemantic proximity Read ↗

Effect of adjuvanting RBD-dimer-based subunit COVID-19 vaccines with Sepivac SWE™.Semantic proximity Read ↗

Alum:CpG adjuvant enables SARS-CoV-2 RBD-induced protection in aged mice and synergistic activation of human elder type 1 immunitySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.